Clinical Trials Logo

Gynecologic Cancer clinical trials

View clinical trials related to Gynecologic Cancer.

Filter by:
  • Available  
  • Page 1

NCT ID: NCT05612191 Available - Gynecologic Cancer Clinical Trials

Catequentinib in Patients Who Have Completed an Advenchen Study (A Compassionate Use Trial)

Start date: n/a
Phase:
Study type: Expanded Access

Catequentinib (AL3818, Anlotinib) has been developed in a variety of clinical studies as single agents or in combination with others. This trial is designed to offer patients who completed an Advenchen sponsored AL3818 related study without progression the opportunity to continue to receive this investigational product in this Post-Trial Access study (a compassionate use trial), if the Investigator believes the patients can benefit from such a treatment and the patients have signed the Informed Consent Form.